Article
Potentially functional genetic variants in RPS6KA4 and MAP2K5 in the MAPK signaling pathway predict HBV-related hepatocellular carcinoma survival.
Molecular carcinogenesis - 1 Sept 2023
Qiu Moqin, Lin Qiuling, Liu Yingchun, Chen Peiqin, Zhou Yunxiang, Jiang Yanji, Zhou Zihan, Wen Qiuping, Zhou Xianguo, Liang Xiumei, Gan Haijie, Yu Hongping
Abstract excerpt
Hepatocellular carcinoma (HCC) ranks the third leading cause of cancer deaths with a dismal 5-year survival rate. The mitogen-activated protein kinase (MAPK) signaling pathway is abnormally activated in HCC to promote growth and aggressive metastatic potential of cancer cells. Therefore, genetic variants in the MAPK signaling pathway may serve as potential predictors of Hepatitis B virus (HBV)-related HCC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
